Cardinal Health (NYSE:CAH) Issues FY 2026 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 10.000- for the period. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CAH. Wells Fargo & Company raised their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. TD Cowen increased their price objective on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Robert W. Baird set a $232.00 price target on Cardinal Health in a research note on Friday, October 31st. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Fourteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $213.40.

Cardinal Health Stock Performance

Shares of CAH opened at $202.42 on Tuesday. The company’s 50-day simple moving average is $204.29 and its 200-day simple moving average is $173.48. Cardinal Health has a 1 year low of $119.25 and a 1 year high of $214.93. The stock has a market capitalization of $48.10 billion, a PE ratio of 30.53, a P/E/G ratio of 1.46 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Hedge Funds Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. CIBC Bancorp USA Inc. purchased a new stake in shares of Cardinal Health during the third quarter worth approximately $6,062,000. Danske Bank A S purchased a new position in Cardinal Health in the third quarter worth approximately $28,817,000. Advisory Services Network LLC grew its holdings in Cardinal Health by 11.1% during the 3rd quarter. Advisory Services Network LLC now owns 6,103 shares of the company’s stock worth $958,000 after acquiring an additional 611 shares in the last quarter. Palisade Asset Management LLC purchased a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $47,000. Finally, Jacobs Levy Equity Management Inc. increased its position in shares of Cardinal Health by 8.3% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 118,961 shares of the company’s stock valued at $18,672,000 after purchasing an additional 9,116 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.